129 related articles for article (PubMed ID: 3657856)
1. Laboratory techniques alternative to in vivo experiments for studying the liberation, penetration and fungicidal action of topical antimycotic agents in the skin, including ciclopiroxolamine.
Dittmar W; Jović N
Mykosen; 1987 Jul; 30(7):326-42. PubMed ID: 3657856
[No Abstract] [Full Text] [Related]
2. Ciclopiroxolamine cream 1%: in vitro and in vivo penetration into the stratum corneum.
Ceschin-Roques CG; Hänel H; Pruja-Bougaret SM; Lagarde I; Vandermander J; Michel G
Skin Pharmacol; 1991; 4(2):95-9. PubMed ID: 1878248
[TBL] [Abstract][Full Text] [Related]
3. Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis.
Bohn M; Kraemer KT
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S57-69. PubMed ID: 11051135
[TBL] [Abstract][Full Text] [Related]
4. Ciclopirox nail lacquer 8%: in vivo penetration into and through nails and in vitro effect on pig skin.
Ceschin-Roques CG; Hänel H; Pruja-Bougaret SM; Luc J; Vandermander J; Michel G
Skin Pharmacol; 1991; 4(2):89-94. PubMed ID: 1831626
[TBL] [Abstract][Full Text] [Related]
5. Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.
Subissi A; Monti D; Togni G; Mailland F
Drugs; 2010 Nov; 70(16):2133-52. PubMed ID: 20964457
[TBL] [Abstract][Full Text] [Related]
6. The dermatopharmacologic profile of ciclopirox 8% nail lacquer.
Bohn M; Kraemer K
J Am Podiatr Med Assoc; 2000; 90(10):491-4. PubMed ID: 11107709
[TBL] [Abstract][Full Text] [Related]
7. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO
Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179
[TBL] [Abstract][Full Text] [Related]
8. [Liberation of ciclopiroxolamine from dermatological preparations (author's transl)].
Petri W
Arzneimittelforschung; 1981; 31(8A):1332-7. PubMed ID: 7197540
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of fungicidal action in vitro and in a skin model considering the influence of penetration kinetics of various standard antimycotics.
Hänel H; Raether W; Dittmar W
Ann N Y Acad Sci; 1988; 544():329-37. PubMed ID: 3214073
[TBL] [Abstract][Full Text] [Related]
10. [In vitro antifungal activity of rilopirox, a new hydroxypyridone antimycotic agent].
Harada I; Mitsui K; Uchida K; Yamaguchi H
Jpn J Antibiot; 1997 Feb; 50(2):195-9. PubMed ID: 9100079
[TBL] [Abstract][Full Text] [Related]
11. Micro-liquid chromatography method for the determination of ciclopiroxolamine after pre-column derivatization in topical formulations.
Belliardo F; Bertolino A; Brandolo G; Lucarelli C
J Chromatogr; 1991 Aug; 553(1-2):41-5. PubMed ID: 1787166
[TBL] [Abstract][Full Text] [Related]
12. Ciclopirox olamine: a hydroxypyridone antifungal agent.
Abrams BB; Hänel H; Hoehler T
Clin Dermatol; 1991; 9(4):471-7. PubMed ID: 1822407
[No Abstract] [Full Text] [Related]
13. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
[TBL] [Abstract][Full Text] [Related]
14. Ciclopirox: an overview.
Gupta AK
Int J Dermatol; 2001 May; 40(5):305-10. PubMed ID: 11554991
[No Abstract] [Full Text] [Related]
15. Interaction between ciclopirox and acenocoumarol.
Morales-Molina JA; Pérez-Moyano R; Fayet-Pérez A; Urquízar-Rodríguez O; Gíménez-López MJ
Eur J Clin Pharmacol; 2013 Mar; 69(3):727-8. PubMed ID: 22791274
[No Abstract] [Full Text] [Related]
16. In Vitro Nail Penetration and Antifungal Activity of Tavaborole, a Boron-Based Pharmaceutical.
Coronado D; Merchant T; Chanda S; Zane LT
J Drugs Dermatol; 2015 Jun; 14(6):609-14. PubMed ID: 26091387
[TBL] [Abstract][Full Text] [Related]
17. Skin uptake and clearance of ciclopirox following topical application.
Nair AB; Singh K; Al-Dhubiab BE; Attimarad M; Harsha S; Alhaider IA
Biopharm Drug Dispos; 2013 Dec; 34(9):540-9. PubMed ID: 24123146
[TBL] [Abstract][Full Text] [Related]
18. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.
Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I
Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159
[TBL] [Abstract][Full Text] [Related]
19. [Ciclopiroxolamine. A pyridone derivative for local use in fungal infections of the skin and nails].
Svejgaard EL
Ugeskr Laeger; 1993 Mar; 155(10):733-5. PubMed ID: 8456522
[No Abstract] [Full Text] [Related]
20. Ciclopirox delivery into the human nail plate.
Hui X; Wester RC; Barbadillo S; Lee C; Patel B; Wortzmman M; Gans EH; Maibach HI
J Pharm Sci; 2004 Oct; 93(10):2545-8. PubMed ID: 15349963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
